Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in leukemia

Menin-MLL inhibitor MI-2 Epigenetic Reader Domain Inhibitor

MLL-fusion-driven leukemia requires SETD2 to safeguard genomic

Pharmacologic Inhibition of the Menin-MLL Interaction Blocks

RNA binding proteins in MLL-rearranged leukemia

Leukemogenesis via aberrant self‐renewal by the MLL/AEP‐mediated

A Menin-MLL Inhibitor Induces Specific Chromatin Changes and

IJMS, Free Full-Text

Structure, function and inhibition of critical protein–protein

Leukemogenesis via aberrant self‐renewal by the MLL/AEP‐mediated

A molecular switch between mammalian MLL complexes dictates

Molecular mechanisms of MLL-associated leukemia

Transcriptional addiction in mixed lineage leukemia: new avenues

Inhibitors of the Menin-Mixed Lineage Leukemia (MLL) Interaction

Trithorax and polycomb cooperation in MLL fusion acute leukemia